| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.05 |